News & Events

Weill Cornell Medicine investigators have revealed the detailed workings of a cell membrane protein that has essential roles in all animals. The discovery could lead to new therapeutic strategies for blood coagulation disorders, cancers and other conditions in which the protein, called a TMEM16 scramblase, works abnormally.

Scramblases operate within cell membranes, where they alter or “scramble” the normal layered...

To Dr. Laura Riley, Weill Cornell Medicine’s prowess in caring for women from birth to adulthood is the institution’s best kept secret.

“Weill Cornell is uniquely positioned to provide exemplary care to women, helping them live longer and healthier, and creating evidence for treatment and prevention,” said Dr. Riley, chair of the Department of Obstetrics and Gynecology and the Given Foundation Professor in Clinical Obstetrics and...

Temporarily disabling a protein complex that organizes DNA into loops inside the cell’s nucleus drastically disrupted the three-dimensional structure of the genome, but surprisingly most genes continued to function as usual, Weill Cornell Medicine researchers found. However, they also discovered a small group of affected genes that play a critical role in guiding cells to become specific types, for example heart, brain, or liver cells.

The...

A team of Weill Cornell Medicine investigators is working to cross-train the next generation of cancer researchers in cancer biology and the use of artificial intelligence tools for research.

As states reassess Medicaid coverage following recent federal policy changes and the end of pandemic-era protections, researchers are advocating for evidence-based health care policy reform and expanded Medicaid coverage for children. Weill Cornell Medicine’s Department of Pediatrics, the Cornell Health Policy Center (CHPC) and Ariadne Labs are collaborating to launch the Era of the Child...

Personalized approaches have dramatically improved outcomes for many patients with non-Hodgkin B-cell lymphomas—blood cancers that arise in immune cells called B cells—yet the same is not true for patients with more rare lymphoma types that originate in immune cells called T cells.

Peripheral T-cell lymphomas comprise diverse blood cancers that have a distinct biology, and survival rates vary widely. Lymphoma specialist Dr....

A $1 million Research Scholar Grant from the American Cancer Society will help a multi-institution team led by Dr. Bishoy Faltas, associate professor of medicine at Weill Cornell Medicine, to develop new therapy combinations for hard-to-treat urinary tract cancers.

New...

Alzheimer’s disease may not be a single illness, but a complex web of overlapping brain disorders that scientists have just started to untangle. Leaders in the field discussed this shift in research at the recent 13th annual Helen and Robert Appel Alzheimer’s Disease Research Institute Symposium held in the Belfer Research Building at Weill Cornell Medicine.

“The vision of the Appel Institute is simple. We wanted to tackle some of the most devastating...

Family physicians who report feeling burned out are nearly 1.5 times more likely to change practices or stop practicing medicine entirely compared to their peers who don’t report burnout, a study by Weill Cornell Medicine researchers found. Physician burnout can include emotional exhaustion,...

Six researchers from Weill Cornell Medicine have received Young Investigator Awards from the Prostate Cancer Foundation. These three-year grants award $225,000 to postdoctoral fellows and early-career faculty, helping to energize the field with fresh ideas. The Weill Cornell investigators are part of thirty-one researchers overall who were selected for the PCF’s Class of 2025 Young Investigators. The awardees will investigate how the disease occurs at a molecular level, search for new...

NEW YORK (March 25, 2026)—Dr. Y. Michael Shim, an esteemed physician-scientist who specializes in advanced pulmonary imaging and obstructive airway diseases, has been named chief of the Division of Pulmonary and Critical Care Medicine at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center, effective April 1.

The division provides expert, comprehensive care for...

Applying artificial intelligence techniques to cardiac ultrasound data may make it easier to identify patients with advanced heart failure, a new study has found. The study—led by investigators at Weill Cornell Medicine, Cornell Tech, Cornell Ann S. Bowers College of Computing and Information Science, Columbia University Vagelos College of Physicians and Surgeons and NewYork-Presbyterian—offers the prospect of better care for many thousands of patients who may be overlooked due to the...

Taylor Lis couldn’t imagine being anything other than a doctor. Meeting new people every day and helping them live healthier lives is a deep passion of hers—one that has motivated her through the past four years as a medical student at Weill Cornell Medical College.

Now, on National Match Day, Lis learned where she’ll complete her residency...

Many of health care’s toughest challenges—from delayed diagnoses to inefficient clinical workflows—are waiting for creative solutions. At the Cornell Health AI Hackathon, student teams spent an intense weekend racing to build some of them.

More than 100 students from across Cornell campuses and 17 other universities gathered in New York City March 6–8 for the hackathon. Organized by Entrepreneurship...

As the conflict engulfing the Middle East complicates clinical instruction for medical students at Weill Cornell Medicine-Qatar, medical education leadership in New York has rapidly launched telehealth electives to help students in Doha complete their education.

An enigmatic type of circulating tumor cell called a dual-positive (DP) cell is associated with shorter survival time in patients with advanced breast cancer, according to a study led by investigators at Weill Cornell Medicine and NewYork-Presbyterian. The findings highlight the potential importance of these under-studied cells in breast cancer progression.

Prior exposure to one strain of influenza virus may weaken children’s ability to mount an effective antibody response against their subsequent exposure to a different flu strain, according to a study led by Weill Cornell Medicine investigators. The analysis of the pediatric response to H3N2 and H1N1 influenza A viruses, two of the most common causes of flu, provides insight into the concept of “immune imprinting,” and supports the idea that childhood vaccination, if...

A gene called FOXJ1 may drive resistance to taxane chemotherapy during treatment for advanced prostate cancer, according to a new study led by investigators at Weill Cornell Medicine and Beth Israel Deaconess Medical Center. The findings provide important new insights into why patients with metastatic disease often stop responding to a key class of life-prolonging chemotherapy drugs after initially benefiting. Given that taxanes remain the only chemotherapy agents with demonstrated survival...

State laws that ban insurance prior authorization for buprenorphine—a leading medication for opioid use disorder—may not help more patients stay in treatment for the recommended minimum of 180 days, Weill Cornell Medicine researchers report. Though prescription buprenorphine can be a life-saving treatment that relieves opioid cravings and withdrawal symptoms, adherence to the medication is low.

Published March 6 in JAMA Health Forum, the...

A machine-learning model developed by Weill Cornell Medicine investigators may provide clinicians with an early warning of a complication that can occur late in pregnancy.